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Introduction
Nocardiosis is an infectious disease caused by an aerobic
Gram-positive bacillus belonging to the Actinomycetales
family that is broadly distributed in soil. Like other bacilli,
Nocardia species cause disease mainly in immunocom-
promised patients, such as renal transplant recipients and
those with diabetes mellitus [1–3]. Skin and lung are the
usual sites of primary infection [4]. The lungs are the most
common site of primary infection, and, in such cases,
patients usually complain of fever and cough. Gradually,
the bacillus spreads through the hematogeneous route to all
regions of the body. Approximately one-half of patients
with systemic nocardiosis have central nervous system
involvement. Nocardia can invade the brain asymptomat-
ically and lodge there silently for months or years. How-
ever, spinal cord involvement is very rare [5].
There are few reports concerning involvement of the
spinal cord, and, to the best of our knowledge, there is only
one previous report of abscess of the cauda equina caused
by Nocardia in an immunocompetent host [1].
In this report, we present a very rare case of Nocardia
infection of the cauda equina, which was initially diag-
nosed as a tumor because of a lack of infectious systemic
symptoms and relevant past history; multiple abscesses in
the brain and the lung portal area were revealed after sur-
gery was performed.
Case report
The patient was a 69-year-old female who presented with
chief complaints of incomplete paralysis of the right lower
extremity and difficulty walking. She had a history of
anxiety, and had been administered tranquilizers. There
was no other pertinent past medical history. She had no
history of employment and the family medical history was
negative.
History of the present illness
In April 2012, the patient experienced lower back pain and
was diagnosed with lumbar spondylolysis at another hos-
pital. Conservative outpatient treatment did not improve
the pain, and after 7 days incomplete paralysis of the right
lower extremity was noted. On magnetic resonance imag-
ing (MRI), a mass in the cauda equina area was revealed
and was initially diagnosed as an intradural, extramedullary
tumor. On the following day, the patient experienced dif-
ficulty walking and was admitted to our hospital.
Neurological and laboratory findings on admission
There was spontaneous pain in the lower lumbar region
independent of mobility. The patient was afebrile, and
there was no tenderness over the spinous processes or
paravertebral muscles.
Muscle weakness was severe in the right lower extremity;
muscle power by manual muscle testing (MMT) was grade
0–1 for the tibialis anterior (TA), grade 2 for the extensor
hallucis longus (EHL) and the extensor digitorum longus
(EDL), grade 2 for the peroneus, grade 0–1 for the
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gastrocnemius, and grade 3 for the hamstrings. No muscle
weakness in the left lower extremity was found. There was a
sensory disturbance in the right fifth lumbar (L5) root area.
Deep tendon reflexes were absent in both lower extremities.
No bladder or bowel disturbances or neurological abnor-
malities of the cranial nerve root areas were found.
Laboratory data was as follows:
Hemoglobin (Hb) 12.5 g/dl, white blood cell (WBC)
5,000/ll
Platelet (PLT) 354,000/ll, blood urea nitrogen (BUN)
11.0 mg/dl
Creatinin (Crea) 0.7 mg/dl, sodium (Na)137 mEq/l,
potassium(K) 4.0 mEq/l
There were no remarkable laboratory findings except a
slight elevation of C-reactive protein (CRP), to 0.77 mg/l.
Imaging findings on admission
On MRI, slight spondylolysis at both L3 and L4 was found,
and there was no lumbar spinal canal stenosis. At the T12/
L1/L2 level, a spindle-shaped intradural lesion was seen on
a sagittal T2-weighted image. The entire outer area of the
lesion was high-intensity, and a round inner area was low-
intensity. On an axial T2-weighted image, the lesion was
seen at the right side within the dura mater, causing the
nerve filaments to shift to the left. The margin of the lesion
was irregular and of low intensity, while the inner area was
mixed high- and iso-intensity (Fig. 1, left). On an enhanced
T1-weighted image, only the margin of the lesion was
enhanced (Fig. 1, right).
The lesion was suspected to be an ependymoma, an
astrocytoma, or a hemorrhage within the cauda equina.
Presurgical clinical course
Seventeen hours after admission, the area of muscle
weakness progressed upward to the level of the iliopsoas
(IP) and the area of sensory disturbance also gradually
spread. The MMT muscle power of the IP and the quad-
ratus femoris (Q) decreased from normal to grade 3.
Despite administration of high-dose methylprednisolone,
the paraplegia worsened, and difficulty with urination
occurred during the first 30 h after admission. Accordingly,
an emergency operation was performed.
Surgery
Laminectomy was performed at the T12/L1/L2 level. A
part of the surface of the cauda equina was revealed to be
yellow in color and expanded. After incision of the lesion,
there was a sudden and unexpected outflow of pus (Fig. 2,
left). The pus was located within the cauda equina, and
debris resembling necrotic tissue covered the inner surface
of the mass; the abscess was evacuated to the greatest
extent possible (Fig. 2, right).
A bacterial examination of the debris revealed colonies
of a Gram-positive bacillus, and on microscopic exami-
nation, irregularly weakly- and strongly-stained, beaded,
branching, thin filaments were observed (Fig. 3). Nocardia
beijingensis was confirmed by culture.
Fig. 1 Left T2-weighted MRI. Slight spondylolysis at both L3 and L4
was found; however, there was no lumbar spinal canal stenosis. At the
T12/L1/L2 level, a spindle-shaped intradural lesion was revealed on a
sagittal T2-weighted image. The entire outer area of the lesion was
high-intensity, and a round inner area was low-intensity. On an axial
T2-weighted image, the lesion was seen at the right side within the
dura mater, causing the nerve filaments to shift to the left. The margin
of the lesion was irregular and of low intensity, while the inner area
was mixed high- and iso-intensity. Right enhanced T1-weighted MRI.
Only the margin of the lesion was enhanced
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Postoperative clinical course
An MRI on postoperative day 21 revealed that the cauda
equina abscess had been completely resected (Fig. 4, left).
As Nocardia infection had been confirmed, a whole-body
computed tomography (CT) scan was performed on post-
operative day 4, which revealed multiple lesions, thought
to be abscesses, within the brain and the left lung portal
area (Fig. 5, left); a brain MRI performed on postoperative
day 14 confirmed presence of abscesses (Fig. 4, right).
From postoperative days 5–14, composite sulfa-
methoxazole-trimethoprim (ST) was administered via
intravenous injection to provide a trimethoprim (TMP)
component of 600 mg per day, and then from days 14 to 56
the comparable dose was administered orally. After day 56,
the dose was reduced to TMP component of 400 mg per
day, and minomycin (MINO) 100 mg per day was added.
On postoperative day 14, laboratory data showed that the
CRP had normalized (0.02 mg/l), and CT on postoperative
days 22 and 32 revealed that the brain and lung lesions had
decreased in size (Fig. 5).
On postoperative day 40, the muscle power of the IP and
the Q had improved to grade 4 by MMT; however, the
muscles below the TA remained weak, at grade 0–1, and
the sensory disturbance and bladder/bowel disturbance
were unchanged. Currently, 7 months after surgery, the
sensory disturbance and bladder/bowel disturbance are
improving, the TA power has improved to grade 4, and the




Nocardiosis is caused by Nocardia species, which com-
prise at least three and perhaps six major subgroups,
including Nocardia asteroids sensu stricto, Nocardia
farcinica, and Nocardia nova [5]. Lung and skin are the
most commonly affected primary sites [4]. In two-thirds of
patients, the lung is the primary site of infection [6], and
bacilli are distributed systemically by the hematogeneous
route. Sixty-four percent of patients are immunocompro-
mised hosts [7]. By microscopic examination, the findings
of irregularly weakly- and strongly-stained, beaded,
branching, thin filaments are extremely important for
identification of Nocardia species [5].
According to Beaman et al. [7], central nervous system
involvement of Nocardia can be seen in almost 50 % of
patients with disseminated nocardiosis, and an intracerebral
Fig. 3 Microscopic
examination (Gram stain).
Multiple colonies were found.
Irregularly weakly- and
strongly-stained, beaded,
branching, thin filaments were
observed
Fig. 2 Intraoperative photographs. Left after incision of the lesion,
there was an outflow of pus. Right debris covering the inner surface of
the mass was evacuated to the greatest extent possible
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parenchymal abscess can form in any region of the brain.
Lerner [5] also reported that approximately 45 % of
patients with systemic nocardiosis have central nervous
system infections. However, spinal cord involvement is
very rare.
Spinal cord involvement of Nocardia
There are few reports concerning abscess of the spinal cord
caused by this bacillus, and, to the best of our knowledge,
there is only one previous report of Nocardia in the cauda
equina. Lee et al. [1] reported an 82-year-old man with
diabetes mellitus who suffered a solitary abscess of the
conus medullaris and underwent surgery.
The salient features of the current case were as follows:
(1) the brain and lungs were infected, but the patient had no
symptoms relating to these lesions, (2) the patient was not
immunocompromised, and (3) there were no abnormalities
of laboratory data except a slight elevation of CRP.
Therefore, initially the lesion was diagnosed as a spinal
tumor. Subsequently, abscesses were found at not only in
the cauda equina but also in the brain and the portal area of
the lung. Probably, the lung was the primary site of
infection, as in most cases, and it disseminated to the brain
hematogeneously. From there the bacillus might have
descended to the cauda equina via the central canal of the
spinal cord. This hypothesis is substantiated by the fact that
the pus was located within the cauda equina.
Fig. 5 Follow-up CT. Left on postoperative day 4, an abscess was found at the left lung portal area, and by day 22, the abscess had decreased in
size. Right a brain abscess, which was identified 1 day after surgery. By postoperative day 32, the abscess had decreased in size
Fig. 4 Postoperative MRI. Left
after surgery, the abscess in the
cauda equina was confirmed to
have been completely resected.
Right multiple brain abscesses
were identified
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Treatment of Nocardia infection
For an abscess in the spinal cord, surgical decompression
and drainage followed by intravenous administration of
effective antibiotics is the standard treatment. For infection
by Nocardia, the first-choice antibiotic is usually com-
posite ST, but the selection of antibiotics should be
determined according to the sensitivity and tolerance of the
isolated organism. Sometimes, amikacin, imipenem, min-
ocycline, or a combination of amoxicillin and clavulanic
acid have been administered. Recently, the efficacy of
linezolid has been reported [9].
The administration of antibiotics must usually be con-
tinued for at least 6 months. However, in patients with an
infected central nervous system, those with multiple
infections and patients with immuno-insufficiency,
the administration must be continued for at least 1 year
[4, 5, 8].
Conclusion
In this report, we present a very rare case of nocardiosis
that manifested initially as a tumor-like configuration in the
cauda equina. The differential diagnosis for an intradural
lesion at the level of the cauda equina must include
abscess, even when obvious signs and symptoms of
infection are not evident.
The patient was informed that we wanted to submit data
from her case for publication, and provided her consent.
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